FormFactor Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 27, 2025 · FY), FormFactor Inc. reported revenue of $785.0M (+2.8% year on year) and net income of $54.4M (-21.9% year on year).
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Revenues | $785.0M | $763.6M | $663.1M | $747.9M |
| Cost of revenues | $476.1M | $455.7M | $404.5M | $451.9M |
| Gross profit | $308.9M | $307.9M | $258.6M | $296.0M |
| Research and development | $115.7M | $121.9M | $115.8M | $109.2M |
| Selling, general and administrative | $133.1M | $141.8M | $133.0M | $131.9M |
| Factory start-up costs | $3.0M | — | — | — |
| Total operating expenses | $251.8M | $263.7M | $248.8M | $241.1M |
| Gain on sale of business | $0 | $20.6M | $73.0M | — |
| Operating income | $57.1M | $64.8M | $82.8M | $54.9M |
| Interest income | $10.6M | $14.1M | $7.2M | $2.2M |
| Interest expense | ($521.0K) | ($418.0K) | ($421.0K) | ($579.0K) |
| Other income (expense), net | $2.2M | $939.0K | ($285.0K) | $1.3M |
| Income before income taxes and equity investment | $69.4M | $79.4M | $89.3M | $57.9M |
| Provision for income taxes | $13.0M | $9.8M | $6.9M | $7.1M |
| Loss from equity investment | $2.0M | — | — | — |
| Net income | $54.4M | $69.6M | $82.4M | $50.7M |
| Basic (in USD per share) | $0.70 | $0.90 | $1.06 | $0.65 |
| Diluted (in USD per share) | $0.69 | $0.89 | $1.05 | $0.65 |
| Basic (in shares) | 77.3M | 77.3M | 77.4M | 77.6M |
| Diluted (in shares) | 78.3M | 78.4M | 78.2M | 78.2M |
| Line item | Jun 27, 2026 · Q2 | Mar 28, 2026 · Q1 | Sep 27, 2025 · Q3 | Jun 28, 2025 · Q2 |
|---|---|---|---|---|
| Revenues | $258.2M | $226.1M | $202.7M | $195.8M |
| Cost of revenues | $127.3M | $139.3M | $122.0M | $122.9M |
| Gross profit | $130.9M | $86.8M | $80.6M | $72.9M |
| Research and development | $31.1M | $30.8M | $28.7M | $28.8M |
| Selling, general and administrative | $37.2M | $32.3M | $33.0M | $31.8M |
| Factory start-up costs | $4.9M | $7.1M | $964.0K | — |
| Total operating expenses | $73.1M | $70.1M | $62.6M | $60.6M |
| Operating income | $57.8M | $16.6M | $18.0M | $12.3M |
| Interest income, net | $2.7M | $2.2M | $2.0M | $2.6M |
| Other income (expense), net | $212.0K | $441.0K | $444.0K | ($6.0K) |
| Income before income taxes and equity investment | $60.7M | $19.3M | $20.4M | $14.9M |
| Provision for income taxes | $6.7M | $396.0K | $5.9M | $2.4M |
| Income (loss) from equity investment | $2.2M | $1.5M | ($1.2M) | $3.5M |
| Net income | $56.2M | $20.4M | $15.7M | $9.1M |
| Basic | $0.72 | $0.26 | $0.20 | $0.12 |
| Diluted | $0.71 | $0.26 | $0.20 | $0.12 |
| Basic | 78.0M | 77.8M | 77.4M | 77.1M |
| Diluted | 79.6M | 79.4M | 77.7M | 77.5M |
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $103.3M | $190.7M | $177.8M | $109.1M |
| Marketable securities | $171.8M | $169.3M | $150.5M | $129.0M |
| Accounts receivable, net | $125.4M | $104.3M | $103.0M | $88.1M |
| Inventories, net | $110.9M | $101.7M | $111.7M | $123.2M |
| Restricted cash | $1.1M | $3.7M | $1.2M | $1.2M |
| Prepaid expenses and other current assets | $44.5M | $35.4M | $29.7M | $23.9M |
| Total current assets | $557.1M | $605.1M | $573.8M | $474.6M |
| Restricted cash | $2.7M | $2.7M | $2.3M | $2.6M |
| Operating lease, right-of-use-assets | $17.2M | $22.6M | $30.5M | $31.4M |
| Property, plant and equipment, net of accumulated depreciation | $259.1M | $210.2M | $204.4M | $189.8M |
| Equity investment | $64.1M | — | — | — |
| Goodwill | $216.0M | $199.2M | $201.1M | $211.4M |
| Intangibles, net | $16.3M | $10.4M | $12.9M | $26.8M |
| Deferred tax assets | $89.5M | $92.0M | $79.0M | $67.6M |
| Other assets | $2.4M | $4.0M | $2.8M | $4.0M |
| Total assets | $1.2B | $1.1B | $1.1B | $1.0B |
| Accounts payable | $47.4M | $62.3M | $63.9M | $69.3M |
| Accrued liabilities | $47.5M | $43.7M | $41.0M | $42.1M |
| Current portion of term loan, net of unamortized issuance cost of $5 and $5 | $1.1M | $1.1M | $1.1M | $1.0M |
| Deferred revenue | $20.1M | $15.8M | $16.7M | $29.8M |
| Operating lease liabilities | $7.7M | $8.4M | $8.4M | $7.4M |
| Total current liabilities | $123.9M | $131.3M | $131.1M | $149.7M |
| Term loan, less current portion, net of unamortized issuance cost of $44 and $49 | $11.1M | $12.2M | $13.3M | $14.4M |
| Deferred tax liabilities | $1.6M | — | $0 | $2.7M |
| Long-term operating lease liabilities | $12.5M | $17.6M | $25.3M | $27.6M |
| Deferred grant | $18.0M | $18.0M | $18.0M | — |
| Other liabilities | $21.9M | $19.3M | $10.2M | $5.6M |
| Total liabilities | $189.0M | $198.4M | $198.0M | $199.9M |
| Preferred stock | $0 | $0 | $0 | $0 |
| Common stock | $78.0K | $77.0K | $77.0K | $77.0K |
| Additional paid-in capital | $863.5M | $837.6M | $861.4M | $844.8M |
| Accumulated other comprehensive loss | ($3.5M) | ($10.8M) | ($4.1M) | ($5.6M) |
| Accumulated income | $175.3M | $120.9M | $51.3M | ($31.1M) |
| Total stockholders’ equity | $1.0B | $947.8M | $908.8M | $808.3M |
| Total liabilities and stockholders’ equity | $1.2B | $1.1B | $1.1B | $1.0B |
| Line item | Jun 27, 2026 | Mar 28, 2026 | Sep 27, 2025 | Jun 28, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $109.8M | $123.5M | $97.7M | $67.4M |
| 235879000 | $235.9M | $179.7M | $168.4M | $181.9M |
| Accounts receivable, net of allowance for credit losses of $6 and $29 | $155.8M | $132.2M | $133.3M | $115.2M |
| Inventories, net | $121.4M | $112.9M | $108.8M | $110.8M |
| Restricted cash | $765.0K | $897.0K | $1.1M | $1.1M |
| Prepaid expenses and other current assets | $45.9M | $51.6M | $50.0M | $48.9M |
| Total current assets | $669.5M | $600.8M | $559.3M | $525.3M |
| Restricted cash | $2.6M | $2.0M | $2.4M | $2.5M |
| Operating lease, right-of-use-assets | $15.1M | $16.4M | $17.5M | $19.5M |
| Property, plant and equipment, net of accumulated depreciation | $265.4M | $248.4M | $257.9M | $259.3M |
| Equity investment | $65.9M | $64.2M | $66.4M | $67.3M |
| Goodwill | $212.6M | $215.4M | $200.8M | $200.9M |
| Intangible assets, net | $18.0M | $15.5M | $8.4M | $9.0M |
| Deferred tax assets | $90.9M | $90.6M | $88.3M | $94.8M |
| Other assets | $2.5M | $2.4M | $2.0M | $3.2M |
| Total assets | $1.3B | $1.3B | $1.2B | $1.2B |
| Accounts payable | $77.4M | $54.2M | $58.4M | $59.9M |
| Accrued liabilities | $53.3M | $42.1M | $41.6M | $38.5M |
| Current portion of long-term debt, net of unamortized issuance costs | $1.2M | $1.1M | $1.1M | $1.1M |
| Deferred revenue | $24.0M | $26.3M | $21.6M | $16.4M |
| Operating lease liabilities | $8.3M | $8.3M | $7.4M | $7.9M |
| Total current liabilities | $164.2M | $132.1M | $130.1M | $124.0M |
| Long-term debt, less current portion, net of unamortized issuance costs | $10.5M | $10.8M | $11.4M | $11.6M |
| Deferred tax liabilities | $2.4M | $1.6M | — | — |
| Long-term operating lease liabilities | $10.0M | $11.6M | $13.3M | $15.2M |
| Deferred grant | $18.0M | $18.0M | $18.0M | $18.0M |
| Other liabilities | $26.1M | $23.0M | $20.6M | $22.7M |
| Total liabilities | $231.1M | $197.1M | $193.4M | $191.6M |
| Common stock, $0.001 par value: | $1.00 | $1.00 | $1.00 | $1.00 |
| Common stock, shares issued (in shares) | 78.1M | 78.0M | 77.5M | 77.1M |
| Common stock, shares outstanding (in shares) | 78.1M | 78.0M | 77.5M | 77.1M |
| Common stock, shares authorized (in shares) | 250.0M | 250.0M | 250.0M | 250.0M |
| Common stock, $0.001 par value: | $78.0K | $78.0K | $78.0K | $77.0K |
| Additional paid-in capital | $870.0M | $870.7M | $857.4M | $850.1M |
| Accumulated other comprehensive loss | ($10.6M) | ($7.7M) | $48.0K | $3.5M |
| Accumulated income | $251.9M | $195.7M | $152.1M | $136.4M |
| Total stockholders’ equity | $1.1B | $1.1B | $1.0B | $990.0M |
| Total liabilities and stockholders’ equity | $1.3B | $1.3B | $1.2B | $1.2B |
| Line item | Dec 27, 2025 · FY | Dec 28, 2024 · FY | Dec 30, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income | $54.4M | $69.6M | $82.4M | $50.7M |
| Depreciation and amortization | $37.6M | $30.3M | $30.6M | $28.6M |
| Accretion of discount on investments | ($2.0M) | ($3.2M) | ($2.8M) | $182.0K |
| Reduction in the carrying amount of right-of-use assets | $6.9M | $6.8M | $7.4M | $8.2M |
| Stock-based compensation expense | $38.6M | $39.8M | $38.6M | $31.3M |
| Deferred income tax provision (benefit) | $1.9M | ($13.4M) | ($12.1M) | ($6.3M) |
| Gain on sale of business | ($103.0K) | ($20.6M) | ($73.0M) | — |
| Provision for excess and obsolete inventories | $14.9M | $12.3M | $15.0M | $24.6M |
| Acquired inventory step-up amortization | $0 | $0 | $501.0K | $476.0K |
| Non-cash restructuring charges | $2.1M | $428.0K | $0 | $200.0K |
| Foreign currency transaction losses | $2.1M | $1.5M | $2.3M | $2.3M |
| Other than temporary impairment on debt receivable | $0 | $0 | $1.1M | — |
| Accounts receivable | ($20.2M) | ($1.9M) | ($23.3M) | $26.0M |
| Inventories | ($20.7M) | ($8.3M) | ($9.5M) | ($28.8M) |
| Prepaid expenses and other current assets | $734.0K | $546.0K | ($3.1M) | ($4.6M) |
| Other assets | ($483.0K) | $285.0K | ($146.0K) | $66.0K |
| Accounts payable | ($5.7M) | ($8.2M) | $1.3M | $3.9M |
| Accrued liabilities | $4.6M | $3.7M | ($2.4M) | ($8.0M) |
| Other liabilities | $2.3M | $9.8M | $4.7M | ($63.0K) |
| Deferred revenues | $4.5M | $2.7M | ($10.2M) | $1.3M |
| Deferred grant | $0 | $0 | $18.0M | — |
| Operating lease liabilities | ($8.1M) | ($7.3M) | ($7.6M) | ($8.0M) |
| Net cash provided by operating activities | $115.4M | $117.5M | $64.6M | $131.8M |
| Acquisition of property, plant and equipment | ($103.7M) | ($38.4M) | ($56.0M) | ($65.3M) |
| Acquisition of business, net of cash acquired | ($20.6M) | $0 | $0 | ($3.4M) |
| Proceeds from sale of business and assets | $103.0K | $21.6M | $101.8M | $0 |
| Purchase of promissory note receivable | $0 | ($1.5M) | $0 | ($1.0M) |
| Purchases of marketable securities | ($126.3M) | ($139.1M) | ($135.5M) | ($101.9M) |
| Proceeds from maturities and sales of marketable securities | $126.1M | $124.0M | $118.8M | $95.8M |
| Net cash provided by (used in) investing activities | ($191.5M) | ($33.5M) | $29.0M | ($75.7M) |
| Proceeds from issuances of common stock | 26.1M | 9.7M | 8.8M | 10.5M |
| Purchase of common stock through stock repurchase program, including excise tax paid | ($26.2M) | ($53.3M) | ($19.8M) | ($82.3M) |
| Tax withholdings related to net share settlements of equity awards | ($12.4M) | ($20.0M) | ($10.7M) | ($15.7M) |
| Payments on term loan | ($1.1M) | ($1.1M) | ($1.0M) | ($8.4M) |
| Net cash used in financing activities | ($13.6M) | ($64.6M) | ($22.7M) | ($95.9M) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ($456.0K) | ($3.5M) | ($2.6M) | ($2.5M) |
| Net increase (decrease) in cash, cash equivalents and restricted cash | ($90.2M) | $15.9M | $68.3M | ($42.4M) |
| Cash, cash equivalents and restricted cash, beginning of year | $197.2M | $181.3M | $113.0M | $155.3M |
| Cash, cash equivalents and restricted cash, end of year | $107.0M | $197.2M | $181.3M | $113.0M |
| Operating lease, right-of-use assets obtained in exchange for lease obligations | $954.0K | $61.0K | $6.5M | $5.0M |
| Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases | ($11.4M) | $7.2M | ($6.0M) | $7.5M |
| Cash paid for income taxes, net | $8.9M | $15.6M | $17.4M | $10.9M |
| Cash paid for interest | $362.0K | $391.0K | $422.0K | $535.0K |
| Operating cash outflows from operating leases | $9.8M | $9.3M | $9.1M | $8.9M |
| Cash and cash equivalents | $103.3M | $190.7M | $177.8M | $109.1M |
| Line item | Jun 27, 2026 · YTD | Mar 28, 2026 · Q1 | Sep 27, 2025 · YTD | Jun 28, 2025 · YTD |
|---|---|---|---|---|
| Net income | $76.6M | $20.4M | $31.1M | $15.5M |
| Depreciation and amortization | $18.1M | $9.2M | $28.2M | $17.1M |
| Reduction in the carrying amount of right-of-use assets | $3.3M | $1.6M | $5.2M | $3.6M |
| Stock-based compensation expense | $16.7M | $8.1M | $28.7M | $19.2M |
| Deferred income tax benefit | ($1.6M) | ($1.1M) | $3.9M | ($2.6M) |
| Provision for excess and obsolete inventories | $7.9M | $4.8M | $9.9M | $6.7M |
| Restructuring charges | $15.7M | $16.0M | $2.1M | $2.2M |
| Income (loss) from equity investment | ($3.8M) | ($1.5M) | $2.3M | $3.5M |
| Other adjustments to reconcile net income to net cash provided by operating activities | ($320.0K) | $25.0K | ($771.0K) | ($1.5M) |
| Accounts receivable | ($30.7M) | ($7.0M) | ($28.1M) | ($9.6M) |
| Inventories | ($19.6M) | ($7.4M) | ($13.9M) | ($12.4M) |
| Prepaid expenses and other current assets | $461.0K | ($5.7M) | ($4.5M) | ($5.7M) |
| Other assets | ($147.0K) | $32.0K | ($69.0K) | $460.0K |
| Accounts payable | $14.5M | $7.5M | $5.7M | $9.6M |
| Accrued liabilities | $5.2M | ($5.3M) | ($996.0K) | ($4.4M) |
| Other liabilities | $4.8M | $1.4M | $596.0K | $2.5M |
| Deferred revenues | $3.4M | $6.0M | $6.2M | $1.1M |
| Operating lease liabilities | ($3.9M) | ($1.9M) | ($6.1M) | ($4.0M) |
| Net cash provided by operating activities | $106.8M | $45.0M | $69.4M | $42.4M |
| Acquisition of property, plant and equipment | ($24.8M) | ($15.2M) | ($92.3M) | ($84.8M) |
| Proceeds from sale of assets | $576.0K | $76.0K | $103.0K | $103.0K |
| Purchase of equity investment | $0 | $0 | ($67.2M) | ($67.2M) |
| Purchases of marketable securities | ($128.7M) | ($37.1M) | ($95.4M) | ($73.8M) |
| Proceeds from maturities and sales of marketable securities | $64.2M | $28.8M | $98.3M | $62.5M |
| Net cash used in investing activities | ($88.7M) | ($23.4M) | ($156.5M) | ($163.2M) |
| Proceeds from issuances of common stock | 5.8M | 5.8M | 26.1M | 21.6M |
| Purchase of common stock through stock repurchase program | $0 | $0 | ($26.2M) | ($24.6M) |
| Tax withholdings related to net share settlements of equity awards | ($16.0M) | ($6.8M) | ($8.6M) | ($3.6M) |
| Payments on term loan | ($564.0K) | ($281.0K) | ($826.0K) | ($549.0K) |
| Net cash used in financing activities | ($10.7M) | ($1.2M) | ($9.6M) | ($7.2M) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | ($1.2M) | ($957.0K) | $537.0K | $1.7M |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $6.1M | $19.4M | ($96.1M) | ($126.3M) |
| Cash, cash equivalents and restricted cash, beginning of year | $107.0M | $107.0M | $197.2M | $197.2M |
| Cash, cash equivalents and restricted cash, end of period | $113.1M | $126.4M | $101.1M | $70.9M |
| Increase (decrease) in accounts payable and accrued liabilities related to property, plant and equipment purchases | $15.8M | ($562.0K) | $10.7M | $13.0M |
| Operating lease, right-of-use assets obtained in exchange for lease obligations | $2.7M | $2.2M | $448.0K | — |
| Cash paid for income taxes, net | $3.0M | $1.0M | $7.6M | $5.4M |
| Cash paid for interest | $168.0K | $85.0K | $276.0K | $187.0K |
| Operating cash outflows from operating leases | $4.6M | $2.2M | $7.3M | $4.9M |
| Cash and cash equivalents | $109.8M | $123.5M | $97.7M | $67.4M |
| Restricted cash, current | $765.0K | $897.0K | $1.1M | $1.1M |
| Restricted cash | $2.6M | $2.0M | $2.4M | $2.5M |
| Total cash, cash equivalents and restricted cash | $113.1M | $126.4M | $101.1M | $70.9M |
FormFactor Inc. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.